MDCXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCXW
Medicus Pharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.65−0.60 (-18.31%)
Close on Oct 19, 2026
- Market cap
- $146.17M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Medicus Pharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| SkinJect Partners LLC | 800,952 | 6.80% | 13G (passive) | Dec 31, 2024 |
| Bokhari, Raza | 4,859,349 | 5.30% | 13D (active) | Sep 4, 2026 |
| Ajay Raju | 2,000,000 | 16.90% | 13G (passive) | Dec 31, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Raza Bokhari | Chief Executive Officer, Director | 3,734,349 | Sep 8, 2026 |
| Andrew Alasdair Smith | Chief Operating Officer | 735,458 | Sep 8, 2026 |
| Carolyn F. Bonner | President and CFO | 1,489,493 | Sep 8, 2026 |
| Edward J. Brennan | Chief Scientific Officer | 674,735 | Sep 8, 2026 |
| Faisal Mehmud | Chief Medical Officer | 1,470,588 | Sep 8, 2026 |
| James P. Quinlan | Chief Financial Officer | 274,147 | Aug 14, 2025 |
| Patrick J. Mahaffy | Director | 35,435 | Jun 4, 2026 |
| William Ashton | Director | 1,250 | Jun 4, 2026 |
| Barry Fishman | Director | – | Jun 4, 2026 |
| Ajay Raju | Director | – | Jun 4, 2026 |
| Robert J. Ciaruffoli | Director | 12,500 | Jun 4, 2026 |
| Sara R. May | Director | – | Jun 4, 2026 |
| Larry Kaiser | Director | – | Jun 4, 2026 |
| Cathy McMorris Rodgers | Director | – | Jun 4, 2026 |
| Frank W. Lavelle | Director | 25,622 | Jan 23, 2025 |
| Velocity Fund Partners, Lp | 10% owner | 3,323,741 | May 21, 2025 |
| Kenneth R. Melani | 10% owner | 3,658,152 | May 21, 2025 |
| PHL Management LLC Togo | 10% owner | – | Dec 31, 2024 |
| 215 Capital TOGO PHL Fund I, LP | 10% owner | 2,000,000 | Dec 31, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Edward J. Brennan Chief Scientific Officer | Sep 4, 2026 | Award | +588,235 | $0.17 | $100.00K | 674,735 |
| Raza Bokhari Chief Executive Officer, Director | Sep 4, 2026 | Award | +2,941,176 | $0.17 | $500.00K | 2,941,176 |
| Andrew Alasdair Smith Chief Operating Officer | Sep 4, 2026 | Award | +735,294 | $0.17 | $125.00K | 735,458 |
| Faisal Mehmud Chief Medical Officer | Sep 4, 2026 | Award | +1,470,588 | $0.17 | $250.00K | 1,470,588 |
| Carolyn F. Bonner President and CFO | Sep 4, 2026 | Award | +1,470,588 | $0.17 | $250.00K | 1,489,493 |
| James P. Quinlan Chief Financial Officer | Aug 13, 2025 | Option exercise | +20,000 | $2.75 | $55.00K | 274,147 |
| James P. Quinlan Chief Financial Officer | Aug 13, 2025 | Option exercise | +125,000 | $0.81 | $101.25K | 254,147 |
| Kenneth R. Melani 10% owner | May 20, 2025 | Sale | −75,000 | $7.72 | $579.00K | 3,248,741 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Velocity Fund Partners, Lp Major Shareholders | May 20, 2025 | 118,000 | $23.07M | May 20, 2025 | Merger |